“We have single-dose ampoules and are now bringing in vials of five doses.
We believe that it will be necessary for the situation in some other countries, for export ... "- RIA Novosti quotes him.
Ishmukhametov also said that KoviVac can be used to revaccinate people who have previously received another coronavirus vaccine.
In October, the Russian Ministry of Health approved clinical trials of the CoviVac coronavirus vaccine on volunteers aged 60 and over.